We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

52 hedge funds and large institutions have $15.3M invested in Niagen Bioscience in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 9

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

19% more capital invested

Capital invested by funds: $12.8M → $15.3M (+$2.46M)

12.16% more ownership

Funds ownership: 0% → 12.16% (+12%)

4% more funds holding

Funds holding: 50 → 52 (+2)

Holders
52
Holders Change
+2
Holders Change %
+4%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$622K
2
BFA
BlackRock Fund Advisors
California
+$322K
3
Morgan Stanley
Morgan Stanley
New York
+$212K
4
AWA
Arete Wealth Advisors
Illinois
+$177K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$155K

Top Sellers

Rank Fund Capital Flow
1
SIM
Spark Investment Management
New York
-$404K
2
SCM
Silver Capital Management
New York
-$352K
3
NSIM
North Star Investment Management
Illinois
-$172K
4
SG Americas Securities
SG Americas Securities
New York
-$85K
5
GIP
Granite Investment Partners
California
-$72.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$65K +$1.43K +526 +3%
UBS Group
27
UBS Group
Switzerland
$64K +$17.1K +6,301 +48%
Creative Planning
28
Creative Planning
Kansas
$63K – – –
Goldman Sachs
29
Goldman Sachs
New York
$62K – – –
NFA
30
Nationwide Fund Advisors
Ohio
$62K – – –
Deutsche Bank
31
Deutsche Bank
Germany
$58K +$36.3K +13,347 +283%
RFC
32
Regions Financial Corp
Alabama
$55K – – –
AIG
33
American International Group
New York
$54K -$120 -44 -0.3%
SCM
34
Silver Capital Management
New York
$45K -$352K -129,453 -91%
LPL Financial
35
LPL Financial
California
$43K – – –
Ameriprise
36
Ameriprise
Minnesota
$39K +$31.9K +11,755 New
CS
37
Credit Suisse
Switzerland
$37K -$302 -111 -1%
MCM
38
MAI Capital Management
Ohio
$35K – – –
BA
39
BlackRock Advisors
Delaware
$30K +$1.83K +675 +8%
Bank of America
40
Bank of America
North Carolina
$28K +$7.45K +2,743 +47%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$24K – – –
Northwestern Mutual Wealth Management
42
Northwestern Mutual Wealth Management
Wisconsin
$12K +$10.2K +3,754 New
Legal & General Group
43
Legal & General Group
United Kingdom
$9K +$7.56K +2,782 New
AWM
44
Avior Wealth Management
Nebraska
$7K – – –
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$7K +$4.9K +1,803 +501%
BlackRock
46
BlackRock
New York
$3K – – –
FANJ
47
Financial Architects (New Jersey)
New Jersey
$3K – – –
IWM
48
IHT Wealth Management
Illinois
$3K +$2.27K +834 New
Barclays
49
Barclays
United Kingdom
$2K +$935 +344 +191%
TRCT
50
Tower Research Capital (TRC)
New York
$2K +$1.55K +572 New
1
2
3

NAGE Hedge Fund Activity: Q4 2016 in Review

52 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q4 2016, worth a combined $15.3M — up 19% from $12.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new NAGE positions and 8 closed out — a net gain of 2 holders — while 15 added to existing stakes and 9 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $622K. The largest seller was Spark Investment Management, exiting entirely with an estimated $404K sold.

  • 52 institutional investors held Niagen Bioscience (NAGE) as of Q4 2016, up from 50 in Q3 2016.
  • Funds reported $15.3M of Niagen Bioscience stock for Q4 2016, up 19% quarter-over-quarter.
  • 10 funds opened new Niagen Bioscience positions in Q4 2016 and 8 closed out, a net change of +2 holders.
  • The largest Niagen Bioscience buyer in Q4 2016 was Millennium Management, an estimated $622K added.
  • The largest Niagen Bioscience seller in Q4 2016 was Spark Investment Management, an estimated $404K sold.

Based on aggregated 13F filings for Q4 2016.